Jun 11, 2020 / 07:00PM GMT
Graig Suvannavejh - Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Great. Good afternoon, everyone. Welcome to the 3 p.m. session of day 3 at the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover European and U.S. biopharma for the firm.
I've got the great pleasure of hosting Genmab today in our fireside chat. With us is Anthony Pagano. He is Executive Vice President and Chief Financial Officer for the company. It's a role that he had -- recently appointed to him.
And with that, Anthony, I want to welcome you to your first GS Global Healthcare Conference. Hopefully, next year, we can do this in person in Southern California.
Anthony Pagano - Genmab A/S-Executive VP&CFO
Yes, Graig. It's an absolute pleasure to be here and look forward to sort of talking about all the exciting stuff that's going on here at Genmab. And I can honestly say, there's really been never more exciting time for the company, and
Genmab A/S at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 12, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers